Cold WFI

Membrane based “Cold” WFI Generation System

In 2017, European Pharmacopoeia (EP) revised its guidelines to allow for an alternative choice in the production of WFI (Water for Injection). The guidelines state that water for injection can be produced using alternative technologies, as long as the quality is equivalent to distillation.

“Cold WFI” is a descriptor for a purification process to produce WFI by means other than distillation. The key difference between the two types of WFI systems is that Cold WFI systems utilize a second membrane barrier, such as low-pressure ultrafiltration (UF), to ensure microbiological quality in place of energy-intensive distillation processes.

Features:

Significantly Lower CAPEX and OPEX costs for Cold WFI.
Reduced carbon Footprint and Increased Sustainability.
More compact in size.

High Purity System

Process System

Value Added Services

Pharma Engineering